Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Agrees To Grant Tamiflu Manufacturing Rights To 15 Companies

This article was originally published in The Pink Sheet Daily

Executive Summary

Teva and Mylan are among the firms that have agreements with Roche to manufacture generic versions of the flu therapy.

You may also be interested in...



Roche Will Sell Tamiflu Under Tiered Pricing System For Pandemic Use

The firm names Shanghai Pharmaceutical Group as the first sub-licensee of the antiviral oseltamivir.

Roche Will Sell Tamiflu Under Tiered Pricing System For Pandemic Use

The firm names Shanghai Pharmaceutical Group as the first sub-licensee of the antiviral oseltamivir.

Roche To Meet With Generic Firms On Tamiflu Rights After Intervention From Senators

Roche agrees to meet with Teva, Mylan, Ranbaxy and Barr to discuss granting manufacturing rights for Tamiflu in order to meet growing global demand for the avian flu antiviral.

Topics

UsernamePublicRestriction

Register

PS061489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel